The financials
Marsh McLennan by the numbers
Marsh McLennan (MRSH) reported revenue of $7.40B in Q2 2026 (quarter ended June 30, 2026), up 6.2% from the same quarter a year earlier. That came with net income of $1.27B (17% of revenue). For the full year FY2025, revenue was $27.0B (+10% year on year) and net income $4.16B. Its largest product in 2026-Q2 was Wealth at $740M, 46% of the disclosed total, just ahead of Health at 38%.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $7.40B | $6.97B | +6.2% |
| Operating income | $1.90B | $1.83B | +3.8% |
| Net income | $1.27B | $1.21B | +4.5% |
| Diluted EPS | $2.63 | $2.45 | +7.3% |
| Product | Revenue | Share |
|---|---|---|
| Wealth | $740M | 46% |
| Health | $611M | 38% |
| Career | $247M | 15% |
Business Segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Q2 2026Total $1.60B (-3.8%)
Career grew +13% year on yearHealth +2.9% year on year
Segment Latestquarter on quarteryear on year
- Wealth$740.0M$740.0MQoQ -1.6%year on year +8.0%-1.6%+8.0%
- Health$611.0M$611.0MQoQ -7.6%year on year +2.9%-7.6%+2.9%
- Career$247.0M$247.0MQoQ -0.40%year on year +13%-0.40%+13%
Insurance Brokers
Ranks #2 of 11 by Smart Score